Navigation Links
PhaseRx Announces Technology Evaluation Agreement with Monsanto
Date:1/24/2013

Seattle, WA. (PRWEB) January 24, 2013

PhaseRx, Inc., a privately held RNAi delivery technology company, announced today that it has signed a funded technology evaluation agreement with Monsanto Company for PhaseRx's delivery technologies. Through the agreement, Monsanto will evaluate PhaseRx's SMARTT Polymer Technology® for potential agricultural applications. Terms of the agreement were not disclosed.

"This agreement with Monsanto represents PhaseRx's first project in the large and growing field of agriculture," said Robert Overell, Ph.D., President and Chief Executive Officer of PhaseRx, Inc. "It also helps further validate the breadth of PhaseRx platform capabilities beyond our primary focus applications."

About PhaseRx

PhaseRx is a privately held RNAi therapeutics company using its proprietary delivery technology to develop personalized medicines against key oncology targets. RNAi therapeutics represent a new class of pharmaceuticals with significant market potential, which has been hindered to date by the lack of effective delivery technology. PhaseRx's SMARTT Polymer Technology® offers effective intracellular RNAi delivery, broad candidate and therapeutic applicability, and robust and reproducible manufacturing. For more information about PhaseRx, please visit http://www.phaserx.com.

###

Read the full story at http://www.prweb.com/releases/2013/1/prweb10353976.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. (Nasdaq: ... focused on advanced wound care, announces that AMNIOEXCEL® ... have been added to the Premier, Inc. Regenerative ... opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product lines, ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... Texas , Dec. 24, 2014  Vermillion, Inc. ... on gynecologic disease, announced today that the Company ... including Oracle Investment Management, Jack W. Schuler ... Total proceeds were $10.5 million, before offering expenses.  ...
Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... , , LAGUNA HILLS, Calif., ... novel biopolymer implant therapies to treat cardiac abnormalities, announced today that ... , , CardioPolymers, Inc. Chief ... effective immediately, better reflects our focus on employing natural biocompatible polymer ...
... ... of Health to develop original in silico technologies to predict 3D structures of RNA-based molecules, ... , ... -- DNA Software, Inc. has been awarded three Fast Track SBIR grants from the National ...
... , PHILADELPHIA, July 22 ERT (Nasdaq: ... eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, ... of Project Management, Tammy Miller. Ms. Miller will report to the ... role, Ms. Miller will be responsible for the global implementation and ...
Cached Biology Technology:Symphony Medical Changes Name to CardioPolymers, Inc. 2DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies 2DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies 3DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies 4ERT Appoints New Vice President of Project Management 2ERT Appoints New Vice President of Project Management 3
(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , a ... will showcase its EyeLock ID technology integrated in a 3D ... Oak Ridge National Laboratory (ORNL) at the 2015 ... authentication technology is being used to validate the driver and ...
(Date:1/22/2015)... YORK , Jan. 21, 2015  Analyst Report Issued by ... Card Brands report showed that planet-wide, transactions at merchants on ... while the total number of credit, debit, and prepaid cards ... U.S. were victims of fraudulent card usage in 2012, and ...
(Date:12/24/2014)... , Dec. 23, 2014  Since its launch in December 2014, the ... eliminate the pain of trying to remember their usernames and ... fused to their smartphones. To assist people who have struggled ... company that created 1U and focuses on redefining identity, announced ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3
... one of the possible causes, of memory loss amongst ... proteins. The aim of this University of the ... location of certain proteins related to Alzheimers. The author ... her work is entitled, Alzheimer gaixotasunarekin erlazionatutako proteinen ultraegitura ...
... want to learn more? You probably aren,t watching television ... Professor Xiaoquan Zhao suggests that watching television has no ... climate change. Reading newspapers and using the web, however, ... The study, "Media Use and Global Warming Perceptions: ...
... This release is available in French . ... HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the ... Their finding was published in the New England Journal ... including Dr. Jean-Pierre Routy of the Research Institute of the ...
Cached Biology News:University of the Basque Country study on proteins related to Alzheimer's 2Television has less effect on education about climate change than other forms of media 2Research shows treating HIV-AIDS with interleukin-2 is ineffective 2
Anti-Mouse Reticular Fibroblast, Purified (Clone ER-TR7) (rat IgG2a)...
...
...
... are predominantly used for labeling proteins, the ... peptides and nucleotides because they give better ... required in the conjugation processes. 5-TAMRA is ... peptides and proteins. 6-TAMRA is predominately used ...
Biology Products: